Latest Breaking News On - Caroline hastings - Page 5 : comparemela.com

Cyclo Therapeutics (CYTH) Provides Business Update

Cyclo Therapeutics Provides Business Update

Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results

16.08.2022 - Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, .

UCSF Children's Hospital doctors raising funds to save puppies in ICU

Husband and wife doctor duo at UCSF Benioff Children's Hospital are raising funds for abandoned puppies in the ICU. 

JTC Team, LLC: JTC Team to Host Virtual Investor Niemann-Pick Disease Type C Spotlight Event Featuring Cyclo Therapeutics

- Live video webcast with moderated fireside chat with members of the Cyclo Therapeutics leadership team and Global Principal Investigator for the Phase 3 study, Professor Caroline Hastings, MD, on Monday